To test or not to test: Blood glucose monitoring for patients with type 2 diabetes
CHAPEL HILL, N.C. – The Patient-Centered Outcomes Research Institute (PCORI) has approved a $2 million research award to the University of North Carolina School of Medicine to study the role of glucose monitoring in patients with type 2 diabetes using oral medications. The three-year project will focus on assessing the impact of three different types of blood sugar or glucose home testing approaches on outcomes important to patients with type 2 diabetes treated in a community-based clinic setting. Katrina Donahue, MD, MPH, associate professor of family medicine, and Laura Young, MD, PhD, assistant professor of medicine, will lead the research project. Both are members of the North Carolina Clinical and Translational Institute, academic home of the National Institute of Health’s Clinical and Translational Science Awards (CTSA). John Buse, MD, PhD, professor of medicine and deputy director of the CTSA, will lead the stakeholder advisory team comprising patients and community members as well as representatives from industry, advocacy groups and state government. The contract from PCORI is for $2,090,699.80. “Given the time and resource-intensive nature of glucose self-monitoring, to test or not to test is a critically important question facing the millions of patients living with non-insulin-treated type 2 diabetes,” said study leaders Drs. Donahue and Young in a written statement. “Patients often receive mixed messages about blood glucose self-monitoring. We are excited that PCORI has recognized the lack of consensus around the utility of glucose monitoring in patients with type 2 diabetes not treated with insulin.” The researchers said this important, patientcentered project will help patients and those that care for them make better, evidence-based decisions about whether or not blood glucose monitoring can improve the outcomes they value most. They also said that the results will shape future decisionmaking in diabetes-care practice and guidelines.